Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site

Authors

Vera J. E. van Vliet, Leiden University
Nitin Sharma, Washington University School of Medicine in St. Louis
Safder S. Ganaie, Washington University School of Medicine in St. Louis
Gaya K. Amarasinghe, Washington University School of Medicine in St. Louis
et al

Journal

PLoS Pathogens

Publication Date

12-1-2022

Volume

18

Issue

12

First Page

e1011065

Document Type

Open Access Publication

DOI

10.1371/journal.ppat.1011065

Rights and Permissions

van Vliet VJE, Huynh N, Palà J, Patel A, Singer A, et al. (2022) Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site. PLOS Pathogens 18(12): e1011065. https://doi.org/10.1371/journal.ppat.1011065. This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Recommended Citation

van Vliet, Vera J. E.; Sharma, Nitin; Ganaie, Safder S.; Amarasinghe, Gaya K.; and et al, "Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site." PLoS Pathogens. 18, 12. e1011065 (2022).
https://digitalcommons.wustl.edu/oa_4/1219

Additional Links

Supplemental material is available for this article at publisher site.